These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 38958627)
21. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells. Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837 [TBL] [Abstract][Full Text] [Related]
22. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies. Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR Cells; 2024 Apr; 13(9):. PubMed ID: 38727281 [TBL] [Abstract][Full Text] [Related]
23. Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy. Ng XY; Peh GSL; Yam GH; Tay HG; Mehta JS Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569804 [TBL] [Abstract][Full Text] [Related]
24. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells. Lin L; Bolund L; Luo Y Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862 [TBL] [Abstract][Full Text] [Related]
25. [Present and Future of an iPS Cell Stock for Regenerative Medicine]. Hanatani T; Takasu N Rinsho Byori; 2017 Feb; 65(2):160-166. PubMed ID: 30762982 [TBL] [Abstract][Full Text] [Related]
26. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications. Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904 [TBL] [Abstract][Full Text] [Related]
27. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017. Kim JH; Alderton A; Crook JM; Benvenisty N; Brandsten C; Firpo M; Harrison PW; Kawamata S; Kawase E; Kurtz A; Loring JF; Ludwig T; Man J; Mountford JC; Turner ML; Oh S; da Veiga Pereira L; Pranke P; Sheldon M; Steeg R; Sullivan S; Yaffe M; Zhou Q; Stacey GN Stem Cells; 2019 Sep; 37(9):1130-1135. PubMed ID: 31021472 [TBL] [Abstract][Full Text] [Related]
28. Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and animal origin-free media. Sekine K; Ogawa S; Tsuzuki S; Kobayashi T; Ikeda K; Nakanishi N; Takeuchi K; Kanai E; Otake Y; Okamoto S; Kobayashi T; Takebe T; Taniguchi H Sci Rep; 2020 Oct; 10(1):17937. PubMed ID: 33087763 [TBL] [Abstract][Full Text] [Related]
29. The march of pluripotent stem cells in cardiovascular regenerative medicine. Abou-Saleh H; Zouein FA; El-Yazbi A; Sanoudou D; Raynaud C; Rao C; Pintus G; Dehaini H; Eid AH Stem Cell Res Ther; 2018 Jul; 9(1):201. PubMed ID: 30053890 [TBL] [Abstract][Full Text] [Related]
30. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances. Chhabra A Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520 [TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells for the treatment of stroke: the potential and the pitfalls. Yu F; Li Y; Morshead CM Curr Stem Cell Res Ther; 2013 Sep; 8(5):407-14. PubMed ID: 23895059 [TBL] [Abstract][Full Text] [Related]
32. Applications of induced pluripotent stem cell technologies in spinal cord injury. Nagoshi N; Okano H J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003 [TBL] [Abstract][Full Text] [Related]
33. Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model. Hong SG; Winkler T; Wu C; Guo V; Pittaluga S; Nicolae A; Donahue RE; Metzger ME; Price SD; Uchida N; Kuznetsov SA; Kilts T; Li L; Robey PG; Dunbar CE Cell Rep; 2014 May; 7(4):1298-1309. PubMed ID: 24835994 [TBL] [Abstract][Full Text] [Related]
34. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Rahimi Darehbagh R; Seyedoshohadaei SA; Ramezani R; Rezaei N Eur J Med Res; 2024 Jul; 29(1):386. PubMed ID: 39054501 [TBL] [Abstract][Full Text] [Related]
35. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Takebe T; Sekine K; Enomura M; Koike H; Kimura M; Ogaeri T; Zhang RR; Ueno Y; Zheng YW; Koike N; Aoyama S; Adachi Y; Taniguchi H Nature; 2013 Jul; 499(7459):481-4. PubMed ID: 23823721 [TBL] [Abstract][Full Text] [Related]
36. Human Induced Pluripotent Stem Cell-Derived Exosomes as a New Therapeutic Strategy for Various Diseases. Wang AYL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578948 [TBL] [Abstract][Full Text] [Related]
37. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine]. Osakada F Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891 [TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells in research and therapy. Teoh HK; Cheong SK Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592 [TBL] [Abstract][Full Text] [Related]
39. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review. Ali EAM; Smaida R; Meyer M; Ou W; Li Z; Han Z; Benkirane-Jessel N; Gottenberg JE; Hua G Stem Cell Res Ther; 2024 Jun; 15(1):185. PubMed ID: 38926793 [TBL] [Abstract][Full Text] [Related]